Developing vaccines and theutic antibodies based on identifying novel, conserved bacterial antigens

UK CEO E-mail address Chief Executive managing director MD UK US America EU customer services care

Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site, we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge

Mr Aubrey is the Chief Executive Officer of IP Group plc, a FTSE 250 company that specialises in commercialising intellectual property. He is also a non-executive chairman of Ceres Power Holdings plc, a manufacturer of advanced solid oxide fuel cells, a non-executive director of Avacta Group plc, an AIM listed company that develops new

EXCLUSIVE: Robin , CEO, Amur Minerals #AMC talks long-term strategy

35 New Broad Street London EC2M 1NH. Telephone +44 (0)20 7194 7622. Disclaimer | Research Disclosures Legal Notice | Terms & Conditions. Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd which is authorised and regulated by the Financial Conduct Authority.

Avacta Group plc (OTC:AVCTF) and OncoSec Medical Incorporated (NASDAQ: ONCS), are pleased to announce they have entered into a research collaboration to combine Avacta’s Affimer protein platform with OncoSec’s gene delivery technology ImmunoPulse. The research programme will evaluate the benefits of

Toplist for [market]. Free real-time prices, and the most active stock market forums.

Newsroom articles are published by leading news agencies. Hargreaves Lansdown is not responsible for an article’s content and its accuracy. We …

FTSE AIM All Share Index share prices – list of all FTSE AIM All Share companies traded on the London Stock Exchange with current price, daily …